Yukihide Ota
Yokohama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Targeting RAD52 overcomes PARP inhibitor resistance in preclinical Brca2-deficient ovarian cancer model.
Journal: bioRxiv : the preprint server for biology
Published: October 03, 2025
Impact of MED12 mutation and CDK8 activity on uterine leiomyoma growth and response to gonadotropin-releasing hormone agonist treatment.
Journal: PloS one
Published: May 21, 2025
Tissue factor pathway inhibitor-2 inhibits integrin β1 activation and focal adhesion formation and suppresses peritoneal ovarian cancer dissemination in mice.
Journal: Biochemical and biophysical research communications
Published: July 12, 2024
A mouse model of deep vein thrombosis by inferior vena cava hypoperfusion using ameroid constrictors.
Journal: Scientific reports
Published: June 14, 2024
Evaluation of X-ray and carbon-ion beam irradiation with chemotherapy for the treatment of cervical adenocarcinoma cells in 2D and 3D cultures.
Journal: Cancer cell international
Published: October 06, 2022
A practical spatial analysis method for elucidating the biological mechanisms of cancers with abdominal dissemination in vivo.
Journal: Scientific reports
Published: May 07, 2022
Lipophagy-ICAM-1 pathway associated with fatty acid and oxygen deficiencies is involved in poor prognoses of ovarian clear cell carcinoma.
Journal: British journal of cancer
Published: September 15, 2021
Machine learning-based image analysis for accelerating the diagnosis of complicated preneoplastic and neoplastic ductal lesions in breast biopsy tissues.
Journal: Breast cancer research and treatment
Published: February 05, 2021
Tissue factor pathway inhibitor‑2 is specifically expressed in ovarian clear cell carcinoma tissues in the nucleus, cytoplasm and extracellular matrix.
Journal: Oncology reports
Published: September 30, 2020
Last Updated: 09/26/2026